HBPSurG 2026

Precision, Innovation, and Future-Proofing in HBP Surgery

Dear Colleagues, Young Specialists, Trainees, and Friends of HBPSurG,

It is with great excitement that we invite you to join us in Lyon, France, for the HBPSurG 2026 Meeting.

Following the success of our previous editions, this year’s event promises to deliver an outstanding, forward-looking scientific program dedicated to empowering the next generation of hepatobiliary and pancreatic surgeons.

Under the theme “Precision, Innovation, and Future-Proofing in Hepato-Biliary & Pancreatic Surgery”, the program features fresh, cutting-edge sessions designed to explore emerging frontiers while maintaining our signature interactive and interdisciplinary approach:

Meet the Experts sessions offering in-depth, case-based explorations of the most complex and novel clinical scenarios. These interactive discussions will cover borderline resectable disease guided by ctDNA and personalized strategies, totally robotic pancreatoduodenectomy in challenging settings, advanced vascular reconstruction with sophisticated planning, and many other cutting-edge topics.
State of the Art lectures delivering the latest updates on transformative topics such as AI and radiomics for future liver remnant prediction and surgical planning, liquid biopsy/ctDNA in recurrence monitoring, neoadjuvant immunotherapy combinations and rescue strategies, functional preservation techniques, long-term quality of life and survivorship in pancreatic cancer, and even sustainability in high-complexity HBP procedures.
Distinguished invited lectures from international leaders in these innovative fields.
Free paper sessions and the Rising Stars Award ceremony to spotlight groundbreaking work from emerging talents.

We are proud to assemble a world-class faculty of renowned experts and rising leaders in HBP surgery, oncology, radiology, and technology integration — many of whom have shaped recent advancements and multicenter trials. Their participation ensures high-quality, evidence-based, and practically relevant content that bridges today’s practice with tomorrow’s possibilities.

This meeting is especially tailored for young HBP specialists and trainees. We strongly encourage you to submit your abstracts for the free paper sessions — whether on precision biomarkers, robotic/minimally invasive extremes, neoadjuvant evolution, functional outcomes, AI applications, or other innovative themes. Your contributions are vital to the vibrancy of our community and offer a unique platform to present your work, receive expert feedback, compete for awards, and network with international peers and mentors.

Mark your calendars and prepare your best work — this is your opportunity to shine and shape the future of our field!We look forward to welcoming you — in person in beautiful Lyon or virtually — for two inspiring days of learning, discussion, and collaboration.

Warm regards,

Prof. Mustapha Adham
On behalf of the HBPSurG Organizing Committee

Prof Philippe Bachellier — Prof P Bachellier
Strasbourg

Prof Luca Gianotti — Prof L Gianotti
Milano

Carl-Stephan Leonhardt — Prof CS Leonhardt
Heidelberg

Romain L'Huillier — Dr R L’Huillier
Lyon

Emmanuel Melloul — Dr E Melloul
Lausanne

Xavier Jean Taverna — Dr XJ Taverna
Lyon

Registration Instructions

1. General registration

Click the above Register here button, select your registration option, complete the form, and submit it.

2. Onsite attendance

– Standard registration: €250
– Standard registration + Congress Dinner: €330
– Resident or Fellow under 35: €150
– Resident or Fellow under 35 + Congress Dinner: €230

Proof of Resident or Fellow status will be required for validation.

3. Speakers with an accepted abstract (free paper sessions)

– Onsite registration is mandatory. If the speaker is not registered, the abstract will be rejected.

4. Resident or Fellow speakers presenting an oral communication

– May apply for the Rising Stars Awards at the time of abstract submission.
– Benefit from free registration. Do not submit the “Register here” form.
– Free registration will be confirmed once the abstract is accepted.

5. Cancellation policy

Registration fees may be refunded until 30 September 2026. A €20 administrative fee will apply.

Abstract Submission Deadline: 15 September

Resident & Fellow Speakers

May apply for “Rising Star Award” on abstract submission.
Benefit from free registration (see registration instructions).

Dr María Cristina du Plessis
Buenos Aires

Implementation of an Early Pancreatic Cancer Detection in the Auvergne–Rhône-Alpes Region (DEPPAN – Early Pancreatic Cancer Detection): Preliminary Results from the HCL Cohort. Khalil Kodroj (Lyon)

Laparoscopic Pancreaticoduodenectomy- Initial experience in a hepatopancreatobiliary high-volume center. Elena-Mihaela Vrabie (Bucharest)

Predictive Factors for Splenectomy During Distal Pancreatectomy with Intended Spleen Preservation Without Splenic Vessels Preservation (Warshaw Procedure). Gaétan Pasinato (Amiens)

Long-term outcomes after Frey or Izbicki procedures for painful calcific chronic pancreatitis: predictive factors for long-term success. Robin Becu (Amiens)

Short-term outcomes of robotic pancreaticoduodenectomy in Western versus Eastern cohorts: a systematic review and meta-analysis. Sophie Rivett (Manchester)

Readmission Is the True Cost of “Early Discharge” After Robotic Pancreaticoduodenectomy: A Systematic Review and Meta-Analysis. Sophie Rivett (Manchester)

Postoperative Hajibandeh Index Predicts Failure to Rescue from Post-Pancreatectomy Fistula and Haemorrhage: A 10-Year Retrospective Cohort Study. Sophie Rivett (Manchester)

Clinical Audit: CEA Follow-Up After Liver Resection for Colorectal Liver Metastases. Esther Sleigh (Southampton)

The impact of age on the outcome of liver surgery: a single-center, retrospective, propensity-score matched cohort study. Max Stauffer (Vienna)

Single-cell Transcriptomics Identifies F11R as a Stromal Mediator Linking Non-alcoholic Fatty Liver Disease and Intrahepatic Cholangiocarcinoma, with Icaritin as a Potential Intervention. Yang Liu (Hangzhou)

Expression of EGFR and Ki-67 in Gall bladder Carcinoma. Mukund Mangarai (New delhi)

Pseudotumoral versus incidental xanthogranulomatous cholecystitis: a comparative analysis of operative complexity and outcomes after laparoscopic cholecystectomy. Maria Cristina du Plessis (Buenos Aires)

Prevalence of Biliary Intraepithelial Neoplasia (BilIN) in laparoscopic cholecystectomies: clinical, surgical, and histopathological associations. Maria Cristina du Plessis (Buenos Aires)

AI-assisted updating and creation of autonomously living guidelines. Max Stauffer (Vienna)

Predicting surgical research using machine learning, graph neural networks and large language models. Max Stauffer (Vienna)

Group & screen in elective laparoscopic cholecystectomy: is it really needed? Sophie Rivett (Manchester)

Heterogeneity in Tokyo Guidelines 2018 grade II acute cholecystitis: association of local complications with operative difficulty and postoperative morbidity. Maria C du Plessis (Buenos Aires)

Bouveret Syndrome and Incidental Gallbladder Carcinoma: A Diagnostic and Therapeutic Challenge. Shirien El Mezin (Standort Judenburg)

Bile leak after elective laparoscopic cholecystectomy: association with transcystic instrumentation and cystic duct closure method. Maria Cristina du Plessis (Buenos Aires)

Management and outcomes of iatrogenic bile duct injuries after cholecystectomy: a 13-year experience from an HPB referral centre. Federico Alberto Niccolò Marin (Milano)

Are We Draining the Right Patients? A Five-Year Audit of Percutaneous Cholecystostomy and Development of a Standardised Management Pathway. Basit Ahmad (Wolverhampton)